TransCode Therapeutics (RNAZ) Q2 2025 Earnings

14MayConfirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-56
-37.53
-19.05
-0.58

Details

Expected EPS
-56
Actual EPS
N/A
Surprise EPS
56
Surprise Percent
+100%

Description

TransCode Therapeutics (RNAZ) will report earnings of for Q2 2025 on May 14, 2025.

0 Comments

Share your thoughts